Candel Therapeutics Inc (CADL)
11.56
-1.14
(-8.98%)
USD |
NASDAQ |
May 17, 16:00
11.51
-0.05
(-0.43%)
After-Hours: 20:00
Candel Therapeutics Shareholders Equity (Quarterly): 5.979M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 5.979M |
December 31, 2023 | 12.74M |
September 30, 2023 | 23.02M |
June 30, 2023 | 30.77M |
March 31, 2023 | 39.65M |
December 31, 2022 | 47.71M |
September 30, 2022 | 52.13M |
Date | Value |
---|---|
June 30, 2022 | 60.07M |
March 31, 2022 | 63.76M |
December 31, 2021 | 64.14M |
September 30, 2021 | 62.99M |
June 30, 2021 | -43.18M |
March 31, 2021 | -27.50M |
December 31, 2020 | -23.56M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-43.18M
Minimum
Jun 2021
64.14M
Maximum
Dec 2021
26.34M
Average
35.21M
Median
Shareholders Equity (Quarterly) Benchmarks
Allurion Technologies Inc | -66.16M |
AngioDynamics Inc | 218.70M |
Eliem Therapeutics Inc | 106.38M |
Macrogenics Inc | 106.15M |
GlycoMimetics Inc | 28.91M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 31.22M |
Total Liabilities (Quarterly) | 25.24M |